Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues

Maher Jedi, Graeme Young, Susanne Pedersen, Erin Symonds

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)
3 Downloads (Pure)


The genes BCAT1 and IKZF1 are hypermethylated in colorectal cancer (CRC), but little is known about how this relates to gene expression. This study assessed the relationship between methylation and gene expression of BCAT1 and IKZF1 in CRC and adjacent non-neoplastic tissues. The tissues were obtained at surgery from 36 patients diagnosed with different stages of CRC (stage I n = 8, stage II n = 13, stage III n = 10, stage IV n = 5). Methylated BCAT1 and IKZF1 were detected in 92% and 72% CRC tissues, respectively, with levels independent of stage (P >.05). In contrast, only 31% and 3% of non-neoplastic tissues were methylated for BCAT1 and IKZF1, respectively (P <.001). The IKZF1 messenger RNA (mRNA) expression was significantly lower in the cancer tissues compared with that of non-neoplastic tissues, whereas the BCAT1 mRNA levels were similar. The latter may be due to the BCAT1 polymerase chain reaction assay detecting more than 1 mRNA transcript. Further studies are warranted to establish the role of the epigenetic silencing of IKZF1 in colorectal oncogenesis.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalClinical Medicine Insights: Oncology
Publication statusPublished - 9 May 2018

Bibliographical note

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (


  • colorectal cancer
  • expression
  • IKZF1
  • BCAT1
  • Methylation


Dive into the research topics of 'Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues'. Together they form a unique fingerprint.

Cite this